Hippo Holdings Inc. (HIPO) stock
Close on Nov 17, 2026Market cap $1.01BP/E 31.1Yield –
Earnings
Hippo's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Hippo's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 24, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 29, 2026after the close | $156.00M | +29.4% | $0.33 | $0.74 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 30, 2026after the close | $144.70M | +23.4% | $0.38 | $0.79 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 30, 2026after the close | $121.50M | +10.5% | $0.27 | $0.65 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 25, 2026after the close | $120.40M | +18.0% | $0.23 | $0.67 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 5, 2025after the close | $120.60M | +26.9% | $3.77 | $0.70 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025after the close | $117.30M | +30.9% | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 7, 2025after the close | $110.00M | +29.3% | -$1.91 | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 6, 2025after the close | $102.00M | +58.1% | $1.71 | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 8, 2024after the close | $95.00M | +64.6% | -$0.34 | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 8, 2024after the close | $89.60M | +87.8% | -$1.64 | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 2, 2024after the close | $85.10M | +113.8% | -$1.47 | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 6, 2024after the close | $64.50M | +80.2% | -$1.76 | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 2, 2023after the close | $57.70M | +87.9% | -$2.24 | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 8, 2023after the close | $47.70M | +66.2% | -$4.61 | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 9, 2023after the close | $39.80M | +65.8% | -$3.01 | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 2, 2023after the close | $35.80M | +11.9% | -$2.74 | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 10, 2022after the close | $30.70M | +44.1% | $5.66 | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 11, 2022after the close | $28.70M | – | -$0.13 | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 13, 2022after the close | $24.00M | – | -$0.12 | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 10, 2022after the close | $32.00M | – | $0.11 | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 10, 2021after the close | $21.30M | – | -$0.08 | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 16, 2021after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Hippo's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| RevenueGAAP | FY2026 | $585.00M – $590.00M | – | New | Oct 28, 2026 |
| Revenue | FY2026 | $580.00M – $585.00M | $560.00M – $570.00M | Raised | Jul 29, 2026 |
| Adjusted Net Income (Loss)non-GAAP | FY2026 | $77.00M – $80.00M | – | New | Oct 28, 2026 |
| Adjusted Net Income (Loss)non-GAAP | FY2026 | $62.00M – $70.00M | $48.00M – $56.00M | Raised | Jul 29, 2026 |
| CAT Loss Ratio | FY2026 | 8% | – | Lowered | Oct 28, 2026 |
| CAT Loss Ratio | FY2026 | 10% | 13% | Lowered | Jul 29, 2026 |
| Combined Ratio | FY2026 | 97% – 98% | – | New | Oct 28, 2026 |
| Combined Ratio | FY2026 | 99% – 101% | 103% – 105% | Raised | Jul 29, 2026 |
| Gross Written Premium | FY2026 | $1.70B – $1.75B | – | New | Oct 28, 2026 |
| Gross Written Premium | FY2026 | $1.65B – $1.70B | $1.45B – $1.53B | Raised | Jul 29, 2026 |
| Net Written Premium | FY2026 | $565.00M – $580.00M | – | Lowered | Oct 28, 2026 |
| Net Written Premium | FY2026 | $565.00M – $580.00M | $520.00M – $550.00M | Lowered | Jul 29, 2026 |
| Stock-based compensation + Depreciation and Amortization | FY2026 | $42.00M | – | Lowered | Oct 28, 2026 |
| Stock-based compensation + Depreciation and Amortization | FY2026 | $42.00M | $42.00M | Lowered | Jul 29, 2026 |
Guidance vs results
The last range Hippo gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $465.00M – $468.00M | $468.30MΣ4Q | Above range |
| Q4 FY2025 | Revenue | $117.00M – $120.00M | $120.40M | Above range |
| Q4 FY2024 | Revenue | $95.00M – $99.00M | $102.00M | Above range |
Guidance history
Every forecast Hippo put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 28, 2026 | Gross Written Premium | FY2026 | $1.70B – $1.75B | New |
| Oct 28, 2026 | Combined Ratio | FY2026 | 97% – 98% | New |
| Oct 28, 2026 | CAT Loss Ratio | FY2026 | 8% | Lowered |
| Oct 28, 2026 | Adjusted Net Income (Loss) | FY2026 | $77.00M – $80.00M | New |
| Oct 28, 2026 | Net Written Premium | FY2026 | $565.00M – $580.00M | Lowered |
| Oct 28, 2026 | Stock-based compensation + Depreciation and Amortization | FY2026 | $42.00M | Lowered |
| Oct 28, 2026 | Revenue | FY2026 | $585.00M – $590.00M | New |
| Jul 29, 2026 | Adjusted Net Income (Loss) | FY2026 | $62.00M – $70.00M | Raised |
| Jul 29, 2026 | Combined Ratio | FY2026 | 99% – 101% | Raised |
| Jul 29, 2026 | CAT Loss Ratio | FY2026 | 10% | Lowered |
| Jul 29, 2026 | Gross Written Premium | FY2026 | $1.65B – $1.70B | Raised |
| Jul 29, 2026 | Net Written Premium | FY2026 | $565.00M – $580.00M | Lowered |
| Jul 29, 2026 | Stock-based compensation + Depreciation and Amortization | FY2026 | $42.00M | Lowered |
| Jul 29, 2026 | Revenue | FY2026 | $580.00M – $585.00M | Raised |
| Apr 29, 2026 | Net Written Premium | FY2026 | $520.00M – $550.00M | Lowered |
| Apr 29, 2026 | Combined Ratio | FY2026 | 103% – 105% | Raised |
| Apr 29, 2026 | CAT Loss Ratio | FY2026 | 13% | Lowered |
| Apr 29, 2026 | Gross Written Premium | FY2026 | $1.45B – $1.53B | Raised |
| Apr 29, 2026 | Stock-based compensation + Depreciation and Amortization | FY2026 | $42.00M | Lowered |
| Apr 29, 2026 | Adjusted Net Income (Loss) | FY2026 | $48.00M – $56.00M | Raised |
| Apr 29, 2026 | Revenue | FY2026 | $560.00M – $570.00M | New |
| Feb 24, 2026 | Gross Written Premium | FY2026 | $1.40B – $1.50B | New |
| Feb 24, 2026 | Net Written Premium | FY2026 | $500.00M – $540.00M | Lowered |
| Feb 24, 2026 | Combined Ratio | FY2026 | 103% – 105% | New |
| Feb 24, 2026 | Adjusted Net Income (Loss) | FY2026 | $45.00M – $55.00M | New |
| Feb 24, 2026 | CAT Loss Ratio | FY2026 | 13% | Lowered |
| Feb 24, 2026 | Stock-based compensation + Depreciation and Amortization | FY2026 | $41.00M | Lowered |
| Nov 4, 2025 | Adjusted Net Income (Loss) | Q4 FY2025 | $10.00M – $14.00M | New |
| Nov 4, 2025 | Net Income (Loss) | Q4 FY2025 | $1.00M – $5.00M | New |
| Nov 4, 2025 | Net Loss Ratio | FY2025 | 63% – 64% | New |
| Nov 4, 2025 | Gross Written Premium | FY2025 | $1.09B – $1.11B | New |
| Nov 4, 2025 | Net Income (Loss) | FY2025 | $53.00M – $57.00M | New |
| Nov 4, 2025 | Adjusted Net Income (Loss) | FY2025 | $10.00M – $14.00M | New |
| Nov 4, 2025 | Net Loss Ratio | Q4 FY2025 | 55% – 60% | Raised |
| Nov 4, 2025 | Gross Written Premium | Q4 FY2025 | $269.00M – $289.00M | New |
| Nov 4, 2025 | Revenue | FY2025 | $465.00M – $468.00M | New |
| Nov 4, 2025 | Revenue | Q4 FY2025 | $117.00M – $120.00M | New |
| Aug 6, 2025 | consolidated net loss ratio | FY2025 | 67% – 69% | New |
| Aug 6, 2025 | Gross Written Premium | FY2025 | $1.07B – $1.10B | New |
| Aug 6, 2025 | net income (loss) | FY2025 | $35.00M – $39.00M | New |
| Aug 6, 2025 | revenue | FY2025 | $460.00M – $465.00M | Lowered |
| May 7, 2025 | annual run-rate of revenue | FY2025 | $500.00M | Raised |
| Mar 5, 2025 | expected PCS CAT load | Q4 FY2025 | 15% | New |
| Mar 5, 2025 | revenue | FY2025 | $465.00M | New |
| Mar 5, 2025 | YoY growth rate from 2024 revenue on a GAAP basis | FY2025 | +25% | New |
| Nov 7, 2024 | adjusted EBITDA | Q4 FY2024 | $5.00M – $6.00M | Reaffirmed |
| Nov 7, 2024 | revenue | Q4 FY2024 | $95.00M – $99.00M | New |
| Aug 7, 2024 | adjusted EBITDA | Q3 FY2024 | -$11.00M – -$9.00M | New |
| Aug 7, 2024 | adjusted EBITDA | Q4 FY2024 | $5.00M – $6.00M | New |
| May 1, 2024 | adjusted EBITDA loss | FY2024 | $41.00M – $51.00M | Reaffirmed |
| May 1, 2024 | TGP | FY2024 | $1.30B | Reaffirmed |
| May 1, 2024 | revenue | FY2024 | $340.00M | New |
| Mar 5, 2024 | adjusted EBITDA loss | FY2024 | $41.00M – $51.00M | New |
| Mar 5, 2024 | HHIP net loss ratio | Q4 FY2024 | 75% | New |
| Mar 5, 2024 | HHIP Gross loss ratio | FY2024 | 72% – 78% | New |
| Mar 5, 2024 | HHIP Net loss ratio | FY2024 | 85% – 90% | Raised |
| Mar 5, 2024 | TGP | FY2024 | $1.30B | New |
| Mar 5, 2024 | Revenue | FY2024 | $340.00M | New |
| Nov 2, 2023 | adjusted EBITDA loss | FY2023 | $207.00M – $212.00M | Raised |
| Nov 2, 2023 | TGP | FY2023 | $1.10B | Raised |
| Nov 2, 2023 | revenue | FY2023 | $190.00M – $195.00M | New |
| Aug 7, 2023 | Adjusted EBITDA | FY2023 | -$218.00M – -$208.00M | Lowered |
| Aug 7, 2023 | TGP | FY2023 | $1.07B | Raised |
| Aug 7, 2023 | Revenue | FY2023 | $178.00M | New |
| May 8, 2023 | adjusted EBITDA loss | FY2023 | -$147.00M | Reaffirmed |
| May 8, 2023 | TGP | FY2023 | $1.00B | Reaffirmed |
| May 8, 2023 | revenues | FY2023 | +45% | Raised |
| Mar 2, 2023 | Adjusted EBITDA | FY2023 | -$147.00M | New |
| Mar 2, 2023 | consolidated TGP | FY2023 | $1.00B | New |
| Mar 2, 2023 | Companywide revenue | FY2023 | +40% | New |
| Nov 10, 2022 | Adjusted EBITDA loss | Q4 FY2022 | $50.00M | New |
| Nov 10, 2022 | Adjusted EBITDA loss | FY2022 | $197.00M – $203.00M | New |
| Nov 10, 2022 | Gross Loss Ratio | FY2022 | 90% | Reaffirmed |
| Nov 10, 2022 | Total Generated Premium | FY2022 | $790.00M – $810.00M | Reaffirmed |
| Nov 10, 2022 | Revenues | FY2022 | $119.00M – $121.00M | Lowered |
| Aug 11, 2022 | Gross Loss Ratio | FY2022 | 90% | Lowered |
| Aug 11, 2022 | TGP | FY2022 | $790.00M – $810.00M | Lowered |
| Aug 11, 2022 | revenue | FY2022 | $119.00M – $121.00M | Lowered |
| May 12, 2022 | Gross Loss Ratio | FY2022 | 100% | New |
| May 12, 2022 | TGP | FY2022 | $800.00M – $820.00M | Reaffirmed |
| May 12, 2022 | Revenue | FY2022 | $140.00M – $142.00M | New |
| Mar 10, 2022 | TGP | FY2022 | $800.00M – $820.00M | New |
| Mar 10, 2022 | revenue | FY2022 | $140.00M – $142.00M | New |
| Nov 10, 2021 | Total Generated Premium | FY2021 | $600.00M – $605.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Hippo filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
See a number that looks wrong?